January 23, 2024 — Siemens Healthineers announces the …
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...
April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...
April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...
February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...
January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...
According to research conducted by Polaris Market Research, the global positron emission tomography (PET)/computed ...
January 16, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
January 5, 2024 — Perspective Therapeutics, Inc., announced that it has entered into a patent license agreement with ...
December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...
December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...
November 30, 2023 — Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the ...
November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...
November 22, 2023 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of the ...
November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...
November 21, 2023 — GE HealthCare has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access ...
November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission ...
November 6, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the National Institute ...